[Analysis of the cost effectiveness ratio of an autotransfusion program for primary prosthetic knee and hip surgery].
M
M
Muñoz Gómez
J J
JJ
García-Vallejo
A
A
Clavero Barranquero
A
A
López-Andrade Jurado
M D
MD
Ruiz Romero de la Cruz
D019644:Arthroplasty, Replacement, Hip / Q000009:adverse effects / Q000191:economics*; D019645:Arthroplasty, Replacement, Knee / Q000009:adverse effects / Q000191:economics*; D001424:Bacterial Infections / Q000209:etiology / Q000276:immunology / Q000517:prevention & control; D016063:Blood Loss, Surgical; D001804:Blood Transfusion, Autologous / Q000191:economics* / Q000379:methods; D003198:Computer Simulation; D003362:Cost-Benefit Analysis; D006801:Humans; D016867:Immunocompromised Host; D007165:Immunosuppression Therapy; D008390:Markov Chains; D011183:Postoperative Complications / Q000209:etiology / Q000276:immunology / Q000517:prevention & control; D015397:Program Evaluation; D013030:Spain; D065227:Transfusion Reaction